The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: A comparative analysis of B-cell and T-cell/natural killer cell lymphomas

International Journal of Hematology

Volumn 77, Issue 3, 2003, Pages 286-294

  Ohno, Tatsuharu ^a   Ueda, Yasunori ^b   Nagai, Ken Ichi ^c   Takahashi, Takayuki ^c   Konaka, Yoshiteru ^d   Takamatsu, Teruyuki ^e   Suzuki, Takayo ^f   Sasada, Masataka ^g   Uchiyama, Takashi ^g  

^a OTSU RED CROSS HOSPITAL   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

^c Kobe Chuo Shimin Byoin   (Japan)

^d Kitano Hospital   (Japan)

^e RAKUWAKAI OTOWA HOSPITAL   (Japan)

^f Medical Center for Adult Diseases   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

Cytokine; Hemophagocytic syndrome; Intravascular lymphomatosis; Malignant lymphoma; Systemic inflammatory response syndrome

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN CELL; LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME; MALE; NATURAL KILLER CELL; PATHOGENESIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0141792696     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983788     Document Type: Article

References (58)

1. Wong KF, Chan JK. Reactive hemophagocytic syndrome: a clinicopathologic study of 40 patients in an Oriental population. Am J Med. 1992;93:177-180.
2. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol. 1997;66:135-151.
3. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood. 1989;73:2128-2132.
4. Ishii E, Ohga S, Aoki T, et al. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol. 1991;85:93-99.
5. Imashuku S, Ikushima S, Esumi N, Todo S, Saito M. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leuk Lymphoma. 1991;3:287-292.
6. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol. 1993;15:92-98.
7. Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon-γ and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994;87:243-250.
8. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Todo S. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol. 1994;88:656-658.
9. Seymour JF, Talpaz M, Cabanillas F, Wetzler M, Kurzrock R. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol. 1995;13:575-582.
10. Imashuku S, Hibi S, Fujiwara F, Toda S. Hyper-interleukin (IL)-6-naemia in haemophagocytic lymphohistiocytosis. Br J Haematol. 1996;93:803-807.
11. Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100-4103.
12. Takada H, Ohga S, Mizuno Y, et al. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol. 1999;106:182-189.
13. Takeshita M, Kikuchi M, Ohshima K, et al. Bone marrow findings in malignant histiocytosis and/or malignant lymphoma with concurrent hemophagocytic syndrome. Leuk Lymphoma. 1993;12:79-89.
14. Yao M, Cheng AL, Su IJ, et al. Clinicopathological spectrum of hemophagocytic syndrome in Epstein-Barr virus-associated peripheral T cell lymphoma. Br J Haematol. 1994;87:535-543.
15. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA. Malignant histiocytosis: a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer. 1990;66:530-536.
16. Reiner AP, Spivak JL. Hematophagic histiocytosis: a report of 23 new patients and a review of the literature. Medicine. 1988;67:369-388.
17. Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 1990;75:434-444.
18. Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathological features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer. 1993;72:909-916.
19. Chang CS, Wang CH, Su IJ, Chen YC, Shen MC. Hematophagic histiocytosis: a clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma. J Formos Med Assoc. 1994;93:421-428.
20. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma. 1995;19:401-406.
21. Wong KF, Chan JKC, Lo ESF, Wong CSC. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol. 1996;27:1239-1242.
22. Kuratsune H, Machii T, Aozaka K, et al. B cell lymphoma showing clinicopathological features of malignant histiocytosis. Acta Haematol. 1988;79:94-98.
23. Nakamoto T, Ogawa S, Mano H, Hirai H, Yazaki Y. Hemophagocytic syndrome associated with non-Hodgkin's lymphoma of B-cell type. Am J Hematol. 1994;47:335-336.
24. Murase T, Nakamura S, Tashiro K, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br J Haematol. 1997;99:656-664.
25. Ohno T, Miyake N, Hada S, et al. Hemophagocytic syndrome in five patients with Epstein-Barr virus-negative B-cell lymphoma. Cancer. 1998;82:1963-1972.
26. Takahashi T, Kanda Y, Mori M, et al. B-cell lymphoma-associated hemophagocytic syndrome after PBSCT. Bone Marrow Transplant. 1998;21:623-625.
27. Shimazaki C, Inaba T, Shimura K, et al. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol. 1999;104:672-679.
28. Takahashi N, Chubati A, Miura I, Nakamura S, Miura T. Lymphoma-associated hemophagocytic syndrome in Japan [in Japanese, abstract in English]. Jpn J Clin Hematol. 1999;40:542-549.
29. Miyahara M, Sano M, Shibata K, et al. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol. 2000;79:378-388.
30. Allory Y, Challine D, Haioun C, et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol. 2001;25:865-874.
31. Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991;77:799-808.
32. Craig FE, Clare CN, Sklar JL, Banks PM. T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol. 1992;97:189-194.
33. Kikuta H, Sakiyama Y, Matsumoto S, et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 1993;82:3259-3264.
34. Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest. 1993;92:1444-1450.
35. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer. 1993;72:2019-2027.
36. Dolezal MV, Kamel OW, van de Rijin M, Cleary ML, Sibley RK, Warnke RA. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol. 1995;103:189-194.
37. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997;100:1969-1979.
38. Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic gamma delta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology. 2000;36:127-135.
39. Ohno T, Kanoh T, Arita Y, et al. Fulminant clonal expansion of large granular lymphocytes: characterization of their morphology, phenotype, genotype, and function. Cancer. 1988;62:1918-1927.
40. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51-55.
41. Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989;73:117-122.
42. Heaney ML, Dolde DW. Soluble cytokine receptors. Blood. 1996;87:847-857.
43. Luoghnan MS, Sanderson CJ, Nossal GJV. Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5. Proc Natl Acad Sci U S A. 1988;85:3115-3119.
44. de Totero D, di Celle PF, Cignetti A, Foa R.The IL-2 receptor complex: expression and function on normal and leukemic B cells. Leukemia. 1995;9:1425-1431.
45. Imashuku S, Hibi S, Tabata Y, Todo S. Hemophagocytic syndrome in five patients with Epstein-Barr virus-negative B-cell lymphoma. Cancer. 1999;85:2298-2300.
46. Abken H, Fluck J, Willecke. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro. J Immunol. 1992;149:2785-2794.
47. Boussiotis VA, Nadler LM, Strominger JL, Goldfeld E. Tumor necrosis factor α is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci U S A. 1994;91:7007-7011.
48. Genestier L, Bonnefoy-Berard N, Rouault JP, Flacher M, Revillard JP. Tumor necrosis factor-α up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. Int Immunol. 1995;7:533-540.
49. Kato H, Kinoshita T, Suzuki S, et al. Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: correlation with extent of IL-6 expression and serum concentration. Br J Haematol. 1996;92:1014-1021.
50. Voorzanger N, Touitou R, Garcia E, et al. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res. 1996;56:5499-5505.
51. Benjamin D, Park CD, Sharma V. Human B cell interleukin 10. Leuk Lymphoma. 1994;12:205-210.
52. Cortes J, Kurzrock R. Interleukin-10 in non-Hodgkin's lymphoma. Leuk Lymphoma. 1997;26:251-259.
53. Khatri VP, Caligiuri MA. A review of the association between interleukin-10 and human B-cell malignancies. Cancer Immunol Immunother. 1998;46:239-244.
54. Ip M, Chan KW, Chan IKL. Systemic inflammatory response syndrome in intravascular lymphomatosis. Intensive Care Med. 1997;23:783-786.
55. Deusch E, Mayer A, Hobisch-Hagen P, et al. Angiotropic large B-cell lymphoma misdiagnosed as urosepsis with multiple organ dysfunction syndrome. Acta Anaesthesiol Scand. 1999;43:100-103.
56. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
57. Romagnani S. Cytokines and the Th1/Th2 paradigm. In: Balkwill F, ed. The Cytokine Network and Immune Functions. Oxford, UK: Oxford University Press; 2000:73-93.
58. Kallio R, Surcel HM, Bloigu A, Syrjala. Balance between interleukin-10 and interleukin-12 in adult cancer patients with or without infections. Eur J Cancer. 2001;37:857-861.